Drugs / CKD-498
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05677438 | Dec 2022 → Dec 2023 | androgenetic alopecia | Chong Kun Dang Pharmaceutical | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CKD-498 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05677438 ↗ |
| Route | Oral | “oral, once daily, 24 weeks” NCT05677438 ↗ |